Athira Pharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $125,466,000.
Profit Margin
| 2018 | 0 | -5.09M | |
|---|---|---|---|
| 2019 | 0 | -4.70M | |
| 2020 | 0 | -18.63M | |
| 2021 | 0 | -54.37M | |
| 2022 | 0 | -87.26M | |
| 2023 | 0 | -117.67M |
ATHA Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 969K | 1.04M | 479K | 2M | 0 | 0 |
Gross profit | -969K | -1.04M | -479K | -2M | 0 | 0 |
Operating exp. | ||||||
Research and development | 93.79M | 61.46M | 42.79M | 13.28M | 3.79M | 3.58M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 125.46M | 88.85M | 55.18M | 18.67M | 4.69M | 5.00M |
Operating income | -125.46M | -104.01M | -64.02M | -19.99M | -5.44M | -5.00M |
Other income (expenses), net | 7.79M | 8.37M | 9.16M | 40K | 288K | -164K |
Income before tax | -117.67M | -95.63M | -54.85M | -19.95M | -5.16M | -5.09M |
Income tax expense | 0 | -8.37M | -479K | -1.32M | -459K | -76K |
Net income | -117.67M | -87.26M | -54.37M | -18.63M | -4.70M | -5.09M |
Earnings per share | ||||||
Basic EPS | -3.1 | -2.31 | -1.47 | -0.57 | -0.14 | -0.82 |
Diluted EPS | -3.09 | -2.31 | -1.47 | -0.57 | -0.14 | -0.82 |
| Data source | Data source | Data source | Data source |